| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 2.98 mm | 2.98 mm | 2.98 mm | 2.98 mm | 2.98 mm | 2.98 mm |
| Cash burn (monthly) | 1.01 mm | 246.83 k | 725.67 k | 1.32 mm | 1.02 mm | 878.67 k |
| Cash used (since last report) | 2.82 mm | 691.58 k | 2.03 mm | 3.71 mm | 2.86 mm | 2.46 mm |
| Cash remaining | 163.39 k | 2.29 mm | 948.83 k | -728.98 k | 117.63 k | 520.15 k |
| Runway (months of cash) | 0.2 | 9.3 | 1.3 | -0.6 | 0.1 | 0.6 |
| 13F holders | Current |
|---|---|
| Total holders | 21 |
| Opened positions | 7 |
| Closed positions | 1 |
| Increased positions | 1 |
| Reduced positions | 2 |
| 13F shares | Current |
|---|---|
| Total value | 335.96 mm |
| Total shares | 4.35 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Acorn Bioventures | 2.82 mm | $0.00 |
| Dellora Investments | 648.75 k | $0.00 |
| CVI Investments | 280.98 k | $2.19 mm |
| Aspire Capital Fund | 270.00 k | $2.28 mm |
| Armistice Capital | 134.00 k | $217.08 mm |
| Eastern Capital | 108.36 k | $436.00 k |
| UBS UBS | 37.98 k | $61.53 mm |
| Point72 Asset Management | 15.33 k | $24.84 mm |
| Acadian Asset Management | 14.29 k | $23.00 k |
| Citadel Advisors | 12.26 k | $19.85 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 29 Jan 24 | Schwartz Brian | Common Stock | Grant | Acquire A | No | No | 0 | 12,500 | 0.00 | 15,205 |
| 29 Jan 24 | Schwartz Brian | Stock Option Common Stock | Grant | Acquire A | No | No | 2.28 | 12,500 | 28.50 k | 12,500 |
| 21 Dec 23 | Spiro George Rombotis | Common Stock | Buy | Acquire P | No | No | 3.315 | 6,070 | 20.12 k | 68,658 |
| 21 Dec 23 | Spiro George Rombotis | Warrants Common Stock | Buy | Acquire P | No | No | 3.19 | 6,070 | 19.36 k | 6,070 |
| 21 Dec 23 | Paul McBarron | Common Stock | Buy | Acquire P | No | No | 3.315 | 1,886 | 6.25 k | 33,378 |
| 21 Dec 23 | Paul McBarron | Warrants Common Stock | Buy | Acquire P | No | No | 3.19 | 1,886 | 6.02 k | 1,886 |
| 30 Jun 23 | Mark Kirschbaum | Stock Option Common Stock | Grant | Acquire A | No | No | 0.5891 | 70,200 | 41.35 k | 70,200 |
| 30 Jun 23 | Walker Karin L | Common Stock | Grant | Acquire A | No | No | 0 | 21,219 | 0.00 | 40,602 |
| 30 Jun 23 | Walker Karin L | Stock Option Common Stock | Grant | Acquire A | No | No | 0.5891 | 42,438 | 25.00 k | 42,438 |
